First in Man Oral
and Parenteral Dosage Forms
SEE ARTICLE
Early-Stage, IND-Enabling Formulations
for PK & Toxicoloxy Studies
SEE ARTICLE
Rapid Development Through
Phase I Clinical Trial Materials
SEE ARTICLE
Formulations for Poorly Soluble
& Low Bioavailability Drugs
SEE ARTICLE
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL
Our Technologies
A wide array of pharmaceutical development capabilities for manufacturing and analyzing drug product dosage forms. READ MORE >
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
SEE ARTICLEPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM

Relationship-based Processes Lead to Enhanced Risk Reduction for Smaller to Mid-size Projects
READ MORE >
The inaugural two-day scientific workshop hosted by Ascendia Pharmaceuticals® was a success at every level. Held in Princeton, NJ, […]
READ MORE >
On October 22-25, Ascendia will participate in the 2023 AAPS PharmSci360 Event at the Orange County Convention Center in Orlando, […]
READ MORE >
Want to learn more about
Ascendia's expertise?
Get up-to-date information